Skip to main content
. 2016 Mar 22;114(7):723–730. doi: 10.1038/bjc.2016.41

Figure 4.

Figure 4

The PK–PD relationship. The data show maximum % PARP inhibition levels relative to pretreatment values (grey circles) plotted against Cmax rucaparib levels (ng ml−1) (inverted white triangles) on day 1 of treatment for all i.v. and oral dose cohorts.